ReShape Lifesciences Inc (RSLS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:ReShape Lifesciences Inc (RSLS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011216
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ReShape Lifesciences Inc(ReShape Lifesciences) formerly known as EnteroMedics Inc, is a medical equipment provider that offers therapeutic and neuroregulator systems. The company designs and develops medical devices for the treatment of obesity and other disorders. It develops VBLOC therapy used in the treatment of gastrointestinal and metabolic diseases. ReShape Lifesciences offers maestro system, components, and other therapy products. The company’s VBLOC therapy is a pacemaker device, which is designed to control hunger. Its products are used in treatment of obesity, co-morbidities, hypertension and digestive disorders. ReShape Lifesciences is headquartered in St. Paul, Minnesota, the US.

ReShape Lifesciences Inc (RSLS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ReShape Lifesciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ReShape Lifesciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ReShape Lifesciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ReShape Lifesciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ReShape Lifesciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ReShape Lifesciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
EnteroMedics Raises USD61 Million in a Venture Financing 10
Partnerships 11
EnteroMedics Enters into Agreement with Galvani Bioelectronics 11
Equity Offering 12
EnteroMedics Raises USD20 Million in Public Offering of Units 12
EnteroMedics Raises USD19 Million in Public Offering of Units 14
EnteroMedics Raises USD16 Million in Public Offering of Units 16
EnteroMedics Announces Public Offering Of Common Stock For US$20 Million 18
EnteroMedics Completes Public Offering Of Common Stock And Warrants For US$13 Million 19
EnteroMedics Announces Private Placement Of Shares For US$45 Million 20
EnteroMedics Completes Private Placement Of Shares For US$3.6 Million Upon Exercise Of Warrants 21
EnteroMedics Completes Private Placement Of Shares For US$5 Million 22
EnteroMedics Completes Underwritten Public Offering Of Common Stock For US$14.5 Million 23
Acquisition 25
EnteroMedics Acquires ReShape Medical 25
EnteroMedics Acquires BarioSurg 27
ReShape Lifesciences Inc – Key Competitors 28
ReShape Lifesciences Inc – Key Employees 29
ReShape Lifesciences Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Corporate Communications 31
Jan 06, 2016: EnteroMedics Announces Senior Level Appointments, New Commercial Operations Organization Structure 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
ReShape Lifesciences Inc, Medical Equipment, Key Facts, 2016 2
ReShape Lifesciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ReShape Lifesciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ReShape Lifesciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ReShape Lifesciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ReShape Lifesciences Inc, Deals By Market, 2011 to YTD 2017 8
ReShape Lifesciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
EnteroMedics Raises USD61 Million in a Venture Financing 10
EnteroMedics Enters into Agreement with Galvani Bioelectronics 11
EnteroMedics Raises USD20 Million in Public Offering of Units 12
EnteroMedics Raises USD19 Million in Public Offering of Units 14
EnteroMedics Raises USD16 Million in Public Offering of Units 16
EnteroMedics Announces Public Offering Of Common Stock For US$20 Million 18
EnteroMedics Completes Public Offering Of Common Stock And Warrants For US$13 Million 19
EnteroMedics Announces Private Placement Of Shares For US$45 Million 20
EnteroMedics Completes Private Placement Of Shares For US$3.6 Million Upon Exercise Of Warrants 21
EnteroMedics Completes Private Placement Of Shares For US$5 Million 22
EnteroMedics Completes Underwritten Public Offering Of Common Stock For US$14.5 Million 23
EnteroMedics Acquires ReShape Medical 25
EnteroMedics Acquires BarioSurg 27
ReShape Lifesciences Inc, Key Competitors 28
ReShape Lifesciences Inc, Key Employees 29
ReShape Lifesciences Inc, Subsidiaries 30

★海外企業調査レポート[ReShape Lifesciences Inc (RSLS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Beneo GmbH:企業の戦略・SWOT・財務分析
    Beneo GmbH - Strategy, SWOT and Corporate Finance Report Summary Beneo GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務分析
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Firstsource Solutions Ltd (FSL):企業の財務・戦略的SWOT分析
    Firstsource Solutions Ltd (FSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • China General Nuclear Power Corp:電力:M&Aディール及び事業提携情報
    Summary China General Nuclear Power Corp (CGN), formerly China Guangdong Nuclear Power Group (CGNPC) is a clean energy company that offers clean energy products and renewable energy services. The company's products include nuclear power and HPR1000, among others. It offers services such as nuclear p …
  • PCI Biotech Holding ASA (PCIB):企業の財務・戦略的SWOT分析
    Summary PCI Biotech Holding ASA (PCI Biotech) is a biopharmaceutical company that focus on development and commercialisation of novel therapies for the treatment of cancer. The company develops therapeutic products based on its proprietary photochemical internalisation technology. Its lead product c …
  • Samsung Medison Co Ltd:企業の戦略的SWOT分析
    Samsung Medison Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Intercontinental Exchange, Inc.:企業のM&A・事業提携・投資動向
    Intercontinental Exchange, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intercontinental Exchange, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Key Energy Services, Inc. (KEG)-石油・ガス分野:企業M&A・提携分析
    Summary Key Energy Services, Inc. (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, …
  • InterContinental Hotels Group Plc:企業の戦略・SWOT・財務情報
    InterContinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report Summary InterContinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Singapore Press Holdings Ltd (T39)
    Singapore Press Holdings Ltd (T39) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • International Consolidated Airlines Group, S.A.:戦略・SWOT・企業財務分析
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Centre for Commercialization of Regenerative Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is an healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, bio materials and devices manufacturing. The center’s cell reprogramming and engineering offers various capabilities such as esta …
  • Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kalgene Pharmaceuticals Inc (Kalgene Pharmaceuticals) is a pre-clinical stage biotechnology company focused on the development of novel fusion protein therapeutic's for the treatment of neurodegenerative diseases. Its lead product candidate KAL-ABP, targets toxic amyloid beta oligomers that …
  • Mckesson Europe AG (CLS1):製薬・医療:M&Aディール及び事業提携情報
    Summary Mckesson Europe AG (Mckesson Europe), formerly known as Celesio AG, is a provider of logistics and services to healthcare and pharmaceutical sectors across Europe. The company is involved in providing distribution solution to its wholesale, institutional and retail customers and delivering p …
  • Tyson Foods Inc:戦略・SWOT・企業財務分析
    Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Alere Toxicology Plc:企業の戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nature’s One, Inc.:企業の戦略・SWOT・財務情報
    Nature’s One, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nature’s One, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Paramount Resources Ltd (POU):企業の財務・戦略的SWOT分析
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • Arab International Bank:企業の戦略・SWOT・財務情報
    Arab International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Canadian Natural Resources Ltd (CNQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing and sale of crude oil, natural gas and natural gas liquids (NGLs). Canadian Natural’s products include light …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆